EyeGene Inc. (KOSDAQ:185490)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,480.00
-25.00 (-1.66%)
At close: Jun 5, 2026

EyeGene Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
7,16210,1941,4255,4962,0462,649
Short-Term Investments
34,30033,30031,12249,87259,08072,680
Trading Asset Securities
226.182,002--5,32910,027
Cash & Short-Term Investments
41,68845,49732,54755,36866,45585,357
Cash Growth
28.87%39.79%-41.22%-16.68%-22.14%163.86%
Accounts Receivable
1,189772.121,415468.06898.07731.32
Other Receivables
-167.4312.04428.64486.97296.1
Receivables
1,189939.531,727896.71,3851,027
Inventory
751.57750.72584.9955.21498.01774.4
Prepaid Expenses
-307.95149.19240.5--
Other Current Assets
363.63141.88289.3317.01492.771,485
Total Current Assets
43,99347,63735,29856,87768,83088,644
Property, Plant & Equipment
5,5165,9929,3159,8515,7425,864
Long-Term Investments
8,8387,74614,1599,3373,8074,076
Other Intangible Assets
2,8932,9014,281982.61844.1761.27
Other Long-Term Assets
3,4603,7502,1501,0551,1585,646
Total Assets
64,70068,05165,30678,10380,381104,991
Accounts Payable
1,4311,3011,680470.69863.841,894
Accrued Expenses
-302.65252.29341.29343.29361.43
Short-Term Debt
--1,7731,4981,3922,995
Current Portion of Leases
165.64168.61179.6314.49392.85272.63
Current Unearned Revenue
-1.330.643.333.23.16
Other Current Liabilities
6,4596,3185,5345,6341,9244,083
Total Current Liabilities
8,0568,0929,4198,2624,9209,609
Long-Term Leases
358.61391.62487.56338.43611.41676.06
Pension & Post-Retirement Benefits
3,0692,9152,5463,4854,6134,055
Long-Term Deferred Tax Liabilities
-----1,168
Other Long-Term Liabilities
294.26490.9437.83626.991,281513.64
Total Liabilities
11,77811,88912,89112,71311,42616,022
Common Stock
21,61521,61513,51513,51510,73910,705
Additional Paid-In Capital
202,340202,340188,325188,329176,131176,277
Retained Earnings
-180,916-177,465-161,740-149,862-129,722-103,829
Comprehensive Income & Other
10,85110,63710,22111,2489,5805,816
Total Common Equity
53,88957,12750,32163,23066,72888,969
Minority Interest
-2,968-2,875513.521,1042,228-
Shareholders' Equity
52,92356,16252,41565,39068,95688,969
Total Liabilities & Equity
64,70068,05165,30678,10380,381104,991
Total Debt
524.25560.242,4412,1512,3973,943
Net Cash (Debt)
41,16444,93630,10753,21764,05881,413
Net Cash Growth
38.04%49.26%-43.43%-16.92%-21.32%434.64%
Net Cash Per Share
1286.061607.061114.592458.552987.224298.37
Filing Date Shares Outstanding
43.1443.2227.0327.0321.4821.41
Total Common Shares Outstanding
43.1443.2227.0327.0321.4821.41
Working Capital
35,93739,54525,87848,61563,91179,034
Book Value Per Share
1249.071321.691861.692339.283106.774155.60
Tangible Book Value
50,99654,22646,04062,24865,88488,208
Tangible Book Value Per Share
1182.011254.561703.312302.933067.474120.04
Machinery
-10,80313,37413,3927,2516,154
Construction In Progress
----102.83613.25